Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid in the Stomach in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes Mellitus

U.S., Dec. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07299084) titled 'A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid in the Stomach in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes Mellitus' on Dec. 10.

Brief Summary: The purpose of this study is to evaluate how fasting and stopping the use of tirzepatide affects the amount of food and drink that stays in the stomach after a meal. Ultrasound will be used to check the stomach content after a test meal.

Study Start Date: Jan., 2026

Study Type: INTERVENTIONAL

Condition: Diabetes Mellitus, Type 2 Overweight Obesity

Interven...